The discovery is the first direct observational confirmation of a theory for how young stars feed on, and then explosively ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
SAN FRANCISCO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...
Over the past decades, a growing number of robotics teams have started developing modular robots inspired by the ancient paper-folding art of origami. More recently, some of these teams started ...
PORTSMOUTH, N.H.--(BUSINESS WIRE)-- Albany International Corp. (NYSE: AIN) announced today that it is exploring strategic alternatives for its structures assembly business, including a potential sale ...
Albany International Initiates Review of Strategic Alternatives for Structures Assembly Business; Announces Loss Reserve Adjustment for CH-53K Program; Schedules Earnings Release Date Third-Quarter ...
State Key Laboratory of Green Chemical Synthesis and Conversion, College of Chemical Engineering, Zhejiang University of Technology, Hangzhou 310014, P. R. China Zhejiang Key Laboratory of Surface and ...
ARRAY Technologies, Inc. announced the successful closing of a private offering of $345 million in convertible senior notes due July 2031, with net proceeds of approximately $334 million. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback